Quantcast

Latest Astute Medical Inc. Stories

2014-10-09 08:27:21

SAN DIEGO, Oct. 9, 2014 /PRNewswire/ -- Astute Medical, Inc. and CRG today announced that Astute recently achieved a milestone under the terms of its existing term loan agreement with CRG. Under the term loan agreement, CRG will provide up to $30 million to support the commercialization of the NephroCheck(®) Test System. An additional $10 million will become available to Astute upon the achievement of certain revenue milestones. Last month, Astute announced receipt of 510(k)...

2014-09-08 08:31:48

NephroCheck® Test System Receives FDA Clearance In United States For Risk Assessment Of Acute Kidney Injury SAN DIEGO, Sept. 8, 2014 /PRNewswire/ -- A novel test used to assess risk for acute kidney injury (AKI) could help physicians significantly improve management of intensive care unit (ICU) patients at risk for AKI, who annually account for 5 million admissions.[1] Inadequacies in assessment and management of AKI have been cited as contributing to an increased number of deaths...

2014-07-28 08:29:05

Collaboration to Expand Sales Breadth and Market Access SAN DIEGO, July 28, 2014 /PRNewswire/ -- Astute Medical, Inc. today announced a strategic collaboration with Ortho-Clinical Diagnostics, Inc. (OCD) that will expand access to a new test that assesses critically ill patients for risk of acute kidney injury (AKI), a prevalent and deadly condition. A study recently published in the Journal of the American Society of Nephrology suggested that AKI could be more deadly than heart attack.(1)...

2014-03-03 08:30:49

Symposium Highlights New Biomarkers for AKI Risk Assessment SAN DIEGO, March 3, 2014 /PRNewswire/ -- Leading critical care experts will discuss biomarkers for risk assessment of acute kidney injury (AKI) at an educational symposium to be held at the19(th) International Conference on Advances In Critical Care - CRRT 2014 in San Diego. The symposium, "New AKI Biomarkers: A Revolution in Risk Assessment," will be held on Thursday, March 6, 2014, from 12:40 p.m. to 2:00 p.m. local time and is...

2014-01-07 08:30:19

SCCM Event Examines Groundbreaking AKI Risk Assessment Biomarkers SAN DIEGO, Jan. 7, 2014 /PRNewswire/ -- An international panel of critical care experts will discuss how new biomarkers for risk assessment of acute kidney injury (AKI) could affect care of critically ill patients at a symposium being held in conjunction with the Society of Critical Care Medicine (SCCM) 43rd Critical Care Congress in San Francisco, Calif. Astute Medical, Inc. is sponsoring the event "Early AKI Assessment: Are...

2011-03-08 11:00:00

SAN DIEGO, March 8, 2011 /PRNewswire/ -- Astute Medical, Inc. today announced the completion of a $13 million financing, which represents an extension of the Series B financing completed by the Company in May 2010. The transaction involved the sale of additional Series B shares to certain existing Series B stockholders including, but not limited to, Domain Associates, Delphi Ventures, De Novo Ventures and Johnson & Johnson Development Corporation. The Company intends to use the...

2010-05-10 06:30:00

SAN DIEGO May 10 /PRNewswire/ -- Astute Medical, Inc., a developer of novel, biomarker-based medical diagnostics, today announced completion of a $26.5 million series B financing co-led by Domain Associates and Delphi Ventures. Astute will use the funding to advance research and development aimed at the identification and validation of protein biomarkers with the goal of commercializing high potential diagnostic products. "Astute Medical is in an excellent position to develop new...


Word of the Day
ramage
  • Boughs or branches.
  • Warbling of birds in trees.
Related